secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emmaus Life Sciences, Inc. (EMMA)
CIK:        0000822370
Form:       8-K
Filed at:   2022-01-10T23:59:59+00:00
Accession:  0001213900-22-001304
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Emmaus Life Sciences appoints Lori Teranishi as director
--------------------------------------------------------

- Board expanded from 7 to 8 on Jan 6, 2022; Teranishi appointed.
- Teranishi is founder & CEO of iQ 360, a strategic communications firm.
- She will receive standard non-employee director compensation per proxy.
- Expected to join board committees when schedule allows.
- No family relationships or related-party transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/822370/000121390022001304/0001213900-22-001304-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/822370/000121390022001304/ea153776-8k_emmauslife.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-001304

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer